Evidence map›Paper›PMID 36209073›Full record

ArticleBMC infectious diseases2022

Characterization of sepsis inflammatory endotypes using circulatory proteins in patients with severe infection: a prospective cohort study.

Isis Ricaño-Ponce, Anca-Lelia Riza, Aline H de Nooijer, Andrei Pirvu, Stefania Dorobantu, Adina Dragos, Ioana Streata, Mihaela Roskanovic, Inge Grondman, Florentina Dumitrescu and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. [Novel strategy of sepsis immunomodulation targeting dendritic cells].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Isis Ricaño-Ponce *Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands. Isis.RicanoPonce@radboudumc.nl.
Anca-Lelia Riza *Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.
Aline H de Nooijer *Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.
Andrei PirvuHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Stefania DorobantuHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Adina DragosHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Ioana StreataHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Mihaela RoskanovicHospital for Infectious Diseases and Pneumology "Victor Babeş" Craiova, Craiova, Romania.
Inge GrondmanDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.
Florentina DumitrescuHospital for Infectious Diseases and Pneumology "Victor Babeş" Craiova, Craiova, Romania.
Vinod KumarDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.
Mihai G NeteaDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.
Mihai IoanaHuman Genomics Laboratory, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
University of Medicine and Pharmacy of Craiova · RORadboud University Medical Center · NLUniversity Medical Center Groningen · NLUniversity of Craiova · RO

Funding

European Research Council 833247European Society of Clinical Microbiology and Infectious Diseases 2017Nederlandse Organisatie voor Wetenschappelijk Onderzoek Spinoza GrantRadboud Universitair Medisch Centrum Hypatia Grant 2018Romanian Ministry of European Funds FUSEZonMw ZonMw COVID-19
6 · The paper itself

Abstract

backgroundSepsis is a heterogeneous syndrome due to a variable range of dysregulated processes in the host immune response. Efforts are made to stratify patients for personalized immune-based treatments and better prognostic prediction. Using gene expression data, different inflammatory profiles have been identified. However, it remains unknown whether these endotypes mirror inflammatory proteome profiling, which would be more feasible to assess in clinical practice. We aim to identify different inflammatory endotypes based on circulating proteins in a cohort of moderately ill patients with severe infection (Sepsis-2 criteria).

methodsIn this prospective study, 92 inflammatory plasma markers were profiled using a targeted proteome platform and compared between patients with severe infection (Sepsis-2 criteria) and healthy controls. To identify endotypes with different inflammatory profiles, we performed hierarchical clustering of patients based on the differentially expressed proteins, followed by clinical and demographic characterization of the observed endotypes.

resultsIn a cohort of 167 patients with severe infection and 192 healthy individuals, we found 62 differentially expressed proteins. Inflammatory proteins such as TNFSF14, OSM, CCL23, IL-6, and HGF were upregulated, while TRANCE, DNER and SCF were downregulated in patients. Unsupervised clustering identified two different inflammatory profiles. One endotype showed significantly higher inflammatory protein abundance, and patients with this endotype were older and showed lower lymphocyte counts compared to the low inflammatory endotype.

conclusionsBy identifying endotypes based on inflammatory proteins in moderately ill patients with severe infection, our study suggests that inflammatory proteome profiling can be useful for patient stratification.

Indexed as

ProteomeSepsisBiomarkersHumansInterleukin-6Prospective StudiesBiomarkersInterleukin-6ProteomeEndotypesHyperinflammationProteomicsSepsisSevere infections

Identifiers

PMID36209073
PMCPMC9547371
OpenAlexW4303645537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.